ClinicalTrials.Veeva

Menu

Potential Pulmonary Benefit of Low Pressure Laparoscopic Cholecystectomy in Selected Patients (POPLOP)

Chinese Academy of Medical Sciences & Peking Union Medical College logo

Chinese Academy of Medical Sciences & Peking Union Medical College

Status

Unknown

Conditions

Cholecystitis; Gallstone
Cholecystitis/Cholelithiasis
Polyp Gallbladder

Treatments

Other: Low Pressure Laparoscopic Cholecystectomy
Other: Standard Pressure Laparoscopic Cholecystectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT04670952
Feng Tian

Details and patient eligibility

About

Standard Pressure Laparoscopic Cholecystectomy,as the standard for cholecystectomy, can lead to about 15% of pulmonary atelectasis. According to literature, low pressure laparoscopic cholecystectomy is thought to probably decrease cardio-pulmonary related complications and postoperative pain. However, the previous studies have presented controversial results. Our study aim to evaluate the potential pulmonary benefit of low pressure laparoscopic cholecystectomy in elderly or patients accompanied with cardio-pulmonary disorders.

Full description

Standard Pressure Laparoscopic Cholecystectomy, SPLC;12-16mmHg,as the standard for cholecystectomy, can lead to about 15% of pulmonary atelectasis.

According to literature, Low Pressure Laparoscopic Cholecystectomy, LPLC;8-10mmHg is thought to probably decrease cardio-pulmonary related complications and postoperative pain. However, most of the existing study have combined population with all age scale, bringing bias to the result. Our study aim to evaluate the potential pulmonary benefit of low pressure laparoscopic cholecystectomy in elderly or patients accompanied with cardio-pulmonary disorders.

Enrollment

140 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Aged 18-85;
  2. Patients receiving laparoscopic cholecystectomy due to benign gallbladder diseases;
  3. Older patient or accompanied by cardiopulmonary diseases (age>60 years, hypertension, Diabetes Mellitus, coronary heart disease, arrhythmia, chronic bronchitis, emphysema, history of heart surgery, history of lung surgery, history of mediastinal surgery, asthma, et al);
  4. Aged older than 60, with or without the above diseases;
  5. American society of Aneshesiologists (ASA) II or higher;
  6. Informed consent acquired.

Exclusion criteria

  1. Having contraindication of laparoscopic operations;
  2. History at epigastric surgery. -

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

140 participants in 2 patient groups

Low Pressure Laparoscopic Cholecystectomy
Experimental group
Description:
LPLC refers to "Low Pressure Laparoscopic Cholecystectomy". In this arm, the pneumoperitoneum pressure is set as 10mmHg.
Treatment:
Other: Low Pressure Laparoscopic Cholecystectomy
Standard Pressure Laparoscopic Cholecystectomy
Other group
Description:
This is taken as the control group. SPLC refers to "Standard Pressure Laparoscopic Cholecystectomy". In this arm, the pneumoperitoneum pressure is set as 14 mmHg.
Treatment:
Other: Standard Pressure Laparoscopic Cholecystectomy

Trial contacts and locations

1

Loading...

Central trial contact

Feng Tian, Doctor; Jun Lu, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems